Bishop, R. T., Li, T., Sudalagunta, P., Nasr, M., Nyman, K. J., Alugubelli, R. R., Meads, M., Frieling, J., Nerlakanti, N., Tauro, M., Fang, B., Grant, S., Koomen, J., Silva, A. S., Shain, K. H. and Lynch, C. C. (2020) “Acid ceramidase controls proteasome inhibitor resistance and is a novel therapeutic target for the treatment of relapsed / refractory multiple myeloma”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2024.285587.